Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days

ClinicalTrials.gov ID: NCT01789736

Public ClinicalTrials.gov record NCT01789736. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 7:00 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study Assessing the Safety and Ocular Hypotensive Efficacy of PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components

Study identification

NCT ID
NCT01789736
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Aerie Pharmaceuticals
Industry
Enrollment
234 participants

Conditions and interventions

Interventions

  • PG286 Ophthalmic Solution 0.5% Drug
  • AR-12286 Ophthalmic Solution 0.5% Drug
  • Travoprost Ophthalmic Solution 0.004% Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2013
Primary completion
May 31, 2013
Completion
May 31, 2013
Last update posted
Mar 16, 2014

2013

United States locations

U.S. sites
21
U.S. states
12
U.S. cities
21
Facility City State ZIP Site status
Kenneth Sall, M.D. Artesia California 90701
United Medical Research Institute Inglewood California 90301
Aesthetic Eye Care Institute Newport Beach California 92657
Bacharach practice Petaluma California 94954
Centre For Health Care Poway California 92064
Clayton Eye Center Morrow Georgia 30260
Coastal Research Associates, LLC Roswell Georgia 30076
Bradley Kwapiszeski, MD Shawnee Mission Kansas 66204
Taustine Eye Center Louisville Kentucky 40217
Alan L Robin, M.D. Baltimore Maryland 21209
Seidenberg Protzko Eye Associates Havre de Grace Maryland 21078
Great Lakes Eye Care Saint Joseph Michigan 49085
Ophthalmic Consultants of Long Island Lynbrook New York 11563
Rochester Ophthalmological Group Rochester New York 14618
Jeffrey Schultz, M.D. The Bronx New York 10467
Charlotte Eye Ear Nose & Throat Associates, P.A. Belmont North Carolina 28012
The Eye Institute Tulsa Oklahoma 74104
Texan Eye Austin Texas 78731
Medical Center Ophth. Associates San Antonio Texas 78731
Stacy R. Smith, M.D. Salt Lake City Utah 84117
Virginia Eye Consultants Norfolk Virginia 23502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01789736, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 16, 2014 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01789736 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →